Oracle Investment Management as of March 31, 2019
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 14 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 29.1 | $125M | 1.9M | 65.47 | |
| Amarin Corporation (AMRN) | 26.2 | $112M | 5.4M | 20.76 | |
| Biohaven Pharmaceutical Holding | 21.2 | $91M | 1.8M | 51.47 | |
| Dermira | 4.3 | $19M | 1.4M | 13.55 | |
| Biolase | 3.4 | $15M | 6.2M | 2.38 | |
| Pacific Biosciences of California (PACB) | 2.7 | $12M | 1.6M | 7.23 | |
| Vermillion | 2.6 | $11M | 9.8M | 1.15 | |
| Motus Gi Hldgs Incorporated | 2.5 | $11M | 2.8M | 3.90 | |
| Opko Health (OPK) | 2.2 | $9.6M | 3.7M | 2.61 | |
| Accelr8 Technology | 1.9 | $8.3M | 4.6M | 1.83 | |
| Soleno Therapeutics | 1.8 | $7.9M | 3.8M | 2.06 | |
| Agenus (AGEN) | 0.9 | $4.0M | 1.4M | 2.97 | |
| Contrafect | 0.5 | $2.2M | 5.6M | 0.40 | |
| Biogen Idec (BIIB) | 0.3 | $1.5M | 6.4k | 236.34 |
